Ionis Pharmaceuticals (IONS) total assets

Total assets · fiscal 2025
$3.52B

Ionis Pharmaceuticals (IONS) had total assets of $3.52B at the end of fiscal 2025 (December 31, 2025). That is 17.3% higher than the $3.00B of fiscal 2024. Figures as of 18 Nov 2026, 01:41 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$3.52B
Change on fiscal 2024
+17.3%
Growth, 5 years
+8.1% a year
Growth, 10 years
+14.0% a year
Highest on record
$3.52Bfiscal 2025
Lowest on record
$484.89Mfiscal 2011
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Ionis Pharmaceuticals total assets, in more detail

Over the five fiscal years to 2025 total assets grew at a compound 8.1% a year; over ten years the rate was 14.0% a year. Across the 17 fiscal years on record (2009–2025), the highest was $3.52B in fiscal 2025 and the lowest $484.89M in fiscal 2011.

History · 17 fiscal years

Total assets by fiscal year

Ionis Pharmaceuticals total assets, year by year

Ionis Pharmaceuticals (IONS) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$3.52B 17.3% up
2024$3.00B 0.5% up
2023$2.99B 18.0% up
2022$2.53B 3.0% down
2021$2.61B 9.3% up
2020$2.39B 26.1% down
2019$3.23B 21.2% up
2018$2.67B 101.7% up
2017$1.32B 45.0% up
2016$912.47M 3.7% down
2015$947.90M 0.8% down
2014$955.81M 12.8% up
2013$847.16M 55.2% up
2012$545.69M 12.5% up
2011$484.89M 11.9% down
2010$550.48M 16.2% down
2009$657.18M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

Total assets at health care companies of similar size

Total assets of Ionis Pharmaceuticals and comparable companies
CompanyTotal assetsFiscal year
Edgewise Therapeutics EWTX$552.60M2025
LivaNova LIVN$2.61B2025
Ionis Pharmaceuticals IONS$3.52B2025
Dianthus Therapeutics DNTH$530.92M2025
MiniMed Group MMED$4.63B2026
Adaptive Biotechnologies ADPT$512.74M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on IONS

Ionis Pharmaceuticals, figure by figure

Ionis Pharmaceuticals (IONS) overview: price, valuation and scorecardAll health care companies by market value

Ionis Pharmaceuticals total assets: questions and answers

How large are Ionis Pharmaceuticals's total assets?

Ionis Pharmaceuticals (IONS) had total assets of $3.52B at the end of fiscal 2025 (December 31, 2025). That is 17.3% higher than the $3.00B of fiscal 2024.

What is the growth rate of Ionis Pharmaceuticals's total assets?

Over the five fiscal years to 2025 total assets grew at a compound 8.1% a year; over ten years the rate was 14.0% a year.

What are the highest and lowest total assets figures on record for Ionis Pharmaceuticals?

Across the 17 fiscal years on record (2009–2025), the highest was $3.52B in fiscal 2025 and the lowest $484.89M in fiscal 2011.

How is Ionis Pharmaceuticals's total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Ionis Pharmaceuticals (IONS) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/IONS/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.